Ashwagandha root vs root and leaf: the difference behind the same percentage

1. Why plant part is a commercial decision, not a footnote

Traditional ashwagandha use is associated with the root. Many premium brands build their story and their label around root-only material. Leaf is a legitimate part of the plant, but it is not the same ingredient, and it is cheaper to harvest at scale. When a supplier blends root and leaf to reach a target withanolide range, the certificate can look identical while the material is different.

This is not a laboratory trick. It is a sourcing decision that should be disclosed. The problem starts when the specification says only 'ashwagandha extract 5% withanolides' and nobody writes down the plant part. Once that happens, the buyer has no contractual basis to reject a root-plus-leaf lot.

2. What the COA can and cannot show

A withanolide result by HPLC tells you the marker content. It does not tell you the plant part. Withaferin A is sometimes reported separately and can differ between root and leaf, but it is not a universal fingerprint. TLC can show a pattern difference, and microscopy can identify leaf tissue in a powdered sample, but neither is a routine release test for every supplier.

The strongest control is documentary and contractual: a specification that names the plant part, a supplier declaration, and a batch record that links the herb lot to the extract lot. Analytical checks then support the declaration rather than replace it.

3. What the label and the market expect

In the US, the ingredient declaration should describe the ingredient accurately; a brand that says 'root extract' should be able to support that with the supplier's specification and records. In the EU, botanical nomenclature and plant part are part of how the ingredient is identified, and member-state expectations vary. Neither market accepts 'ashwagandha extract' as a complete description of a root-only claim.

Ask your regulatory advisor how the plant part should appear on the finished label, and make sure the supplier's specification uses the same wording. A mismatch between the label and the supplier document is a problem that surfaces at the worst possible time.

4. How to write a root-only specification

Start with the botanical name and the part: Withania somnifera root extract. State the withanolide range and the method — for example 4.5–5.5% total withanolides by HPLC — and add a plant-part declaration as a release condition. If withaferin A matters to your positioning, specify whether it is reported and at what range.

Add a change-control clause: any change in plant part, solvent, carrier, or marker method requires written approval before shipment. That clause is what prevents a silent substitution between the sample and the second order.

• Botanical name and plant part, not only the trade name
• Marker range and analytical method
• Carrier and extraction solvent
• Plant-part declaration as a release condition
• Written approval for any change between lots

5. What to check on the sample

Test the sample for withanolides by HPLC and compare the chromatogram with the reference. Ask for the plant-part declaration and the herb lot reference. If the brand story depends on root-only, consider an independent microscopy or DNA-based check for the first lot, especially when the price is materially below the market for root material.

Keep half the sample. When the production lot arrives, compare it with the sample and with the first COA. Consistency between the sample and the commercial lot is the real test of a supplier.

References and further reading

• USP — Public standards ↗
• FDA — Dietary supplement labeling ↗